|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-cells
1 Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark; Department of Endocrinology and Internal Medicine, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark; Clinical Trial Unit, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark
2 Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark; Clinical Trial Unit, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark
3 Steno Diabetes Center, Gentofte, Copenhagen, Denmark
4 Copenhagen Muscle Research Centre, The Panum Institute, University of Copenhagen, Copenhagen, Denmark; Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen, Denmark
5 Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen, Denmark
6 Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark
7 Department of Endocrinology and Internal Medicine, Hvidovre University Hospital, Hvidovre, Copenhagen, Denmark
* To whom correspondence should be addressed. E-mail: sbhau{at}dadlnet.dk.
We examined whether plasma concentrations of non-glucose insulin secretagogues are associated with
prehepatic insulin secretion rates (ISR) in non-diabetic, insulin resistant, human immunodeficiency virus
(HIV)-infected, lipodystrophic patients (LIPO). Additionally, the negative feedback of insulin on ISR was
evaluated. ISR were estimated by deconvolution of plasma C-peptide concentrations during fasting (basal)
and during the last 30 min of a 120 min euglycemic insulin clamp (40 mU/m2). Eighteen normoglycemic LIPO
were compared with 25 normoglycemic HIV-infected patients without lipodystrophy (controls). Thirty minutes
before start of the clamp, a bolus of glucose was injected intravenously to stimulate endogenous insulin
secretion. Insulin sensitivity index (SiRD) was estimated from glucose tracer analysis.
LIPO displayed increased basal ISR (40%), clamp ISR (53%), basal insulin (56%), and clamp insulin (24%),
all P 0.001, whereas Si RD was decreased (57%, P<0.001). In LIPO, ISRbasal correlated significantly with basal
insulin, alanine and glucagon (all r>0.65, P<0.01), but not with glucose. In controls, ISRbasal correlated
significantly with insulin, glucagon and glucose (all r>0.41, P<0.05), but not with alanine. In LIPO, ISRclamp
correlated significantly with clamp free fatty acids (FFA), alanine, triglyceride, and glucagon (all r>0.51,
P<0.05). In controls, ISRclamp correlated with triglyceride (r=0.45, P<0.05). Paradoxically, in LIPO, ISRclamp
correlated positively with clamp insulin (r=0.68, P<0.01), which suggests an absent negative feedback of
insulin on ISR.
Our data support that lipodystrophic, non-diabetic, HIV-infected patients exhibit increased ISR, which can be
partially explained by an impaired negative feedback of insulin on
-cells and an increased stimulation of ISR
by FFA, alanine, triglyceride, and glucagon.
This article has been cited by other articles:
![]() |
C. Hoppe, G. S. Andersen, S. Jacobsen, C. Molgaard, H. Friis, P. T. Sangild, and K. F. Michaelsen The Use of Whey or Skimmed Milk Powder in Fortified Blended Foods for Vulnerable Groups J. Nutr., January 1, 2008; 138(1): 145S - 161S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |